Aposense Ltd.

Aposense Ltd. (Aposense), is a molecular imaging and drug development company engaged in the development of innovative products, diagnostics, and therapies based on the identification and targeting of cells undergoing apoptosis (programmed cell death). It is formerly known as Neurosurvival Technologies Ltd. (NST). Its product pipeline is based on its patented Aposense platform technology. Aposense is a set of small and rationally-designed molecules for clinical use. The company is focused on developing Aposense products in the molecular imaging and the therapeutic areas. Aposense is head quartered in Petach-Tikva, Israel.

Recently Aposense and IBA Sign Strategic Collaboration to Commercialize Aposense ML-10 for Molecular Imaging of Apoptosis.

Street: 
5-7 Odem St.
City: 
Petach-Tikva
Postcode: 
49170
Federal State : 
Israel
WebSite: 
www.aposense.com
Fax: 
972-3-9215714

Company Index Score

Current Index Score Historical Index Score
  • Aposense Ltd. currently scores 50 % in the index.
  • Aposense Ltd. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Aposense Ltd. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets